首頁 > 市場調查報告書 > 醫療設備

病患監測呼吸器

市場調查報告書

商品編碼

1304528

全球呼吸監測設備市場 - 2023-2030

Global Respiratory Monitoring Devices Market - 2023-2030

出版日期: 2023年07月07日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球呼吸監測設備市場規模在2022年達到46億美元，預計到2030年將實現利潤豐厚的成長，達到93億美元。預計在2023-2030年期間，全球呼吸監測設備市場將呈現9.3%的複合年成長率。

呼吸監測設備評估呼吸道的正常運行和氧氣輸送。目前正在開發幾種呼吸測試，以評估肺部在交換呼吸氣體和發現呼吸道堵塞方面的功效。呼吸監測設備的銷售用於擴大呼吸監測設備市場。

呼吸監測設備追踪與呼吸有關的參數，有助於診斷呼吸系統疾病。日益嚴重的空氣污染、呼吸系統疾病病例、老年人口和市場發展促進了全球呼吸監測設備市場的發展。

市場動態

老年人口增加

在預測期內，老年人口的增加是推動市場成長的重要因素之一。老年人口的增加導致呼吸監測設備的增加，因為在這個年齡段人的免疫系統變得脆弱，呼吸監測設備的使用是必不可少的，這確實有助於市場在預測期內的成長。

例如，根據NCBI發表的文章，吸煙者、酗酒者、使用多種藥物和合併其他疾病是影響感染呼吸系統疾病的老年人治療效果的因素，這些老年人確實需要呼吸監測設備，這有助於未來市場的成長。

醫療保健支出增加

已開發國家和發展中國家醫療保健支出的成長推動了呼吸護理設備市場的發展。這是由於這些國家的政府在提高醫療設施品質方面的支出。此外，新興國家人均醫療保健支出的成長等因素（主要是由於政府計劃的增加）將有可能提高治療的可負擔性和可及性，從而推動市場擴張。

例如，根據國際呼吸學會論壇的數據，哮喘和慢性阻塞性肺疾病每年導致約48.9萬人死亡，即每天有1300多人死亡，影響全球2億多人，其中6500萬人患有中度或重度氣道疾病。因此，慢性阻塞性肺病和哮喘等呼吸系統疾病發病率的上升推動了市場的發展。

缺乏對呼吸監測設備的認知

市場成長的阻礙因素之一是缺乏對呼吸監測設備的認知。缺乏資訊和設備的使用將導致市場成長放緩。

許多情況都會影響市場，包括個人不了解這些設備，不能識別呼吸系統疾病的早期症狀和體徵，或不需要監測呼吸系統健康狀況。這就造成了就醫的延誤，從而導致診斷和治療的延遲。

COVID-19影響分析

隨著全球COVID-19病例的增加，對包括脈搏血氧儀、呼吸機和肺活量計在內的呼吸監測設備的需求急劇上升。這些設備對於監測血氧飽和度水準、肺功能以及為急性呼吸窘迫患者提供呼吸輔助至關重要。供應鏈問題也是一個因素，呼吸監測設備需求的成長給全球供應鏈帶來了壓力。

俄烏戰爭影響分析

據估計，俄烏衝突對全球呼吸監測設備市場的影響不大，因為該地區的主要市場參與者較少。然而，原料進出口的影響預計在預測期內對全球呼吸監測設備市場成長的影響不大。

Market Overview

The Global Respiratory Monitoring Devices Market reached US$ 4.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 9.3 billion by 2030. The global respiratory monitoring devices market is expected to exhibit a CAGR of 9.3% during the forecast period 2023-2030.

A Respiratory Monitoring Device Evaluates the airways' regular operation and oxygen delivery. Several respiratory tests are being developed to evaluate the efficacy of the lungs in exchanging breathing gases and finding respiratory tract blockages. Sales of respiratory monitoring devices are used to augment the respiratory monitoring device market.

Respiratory Monitoring Devices track parameters related to breathing, which help diagnose respiratory illnesses. The growing air pollution, cases of respiratory disorders, geriatric population, and market developments promote the global respiratory monitoring devices market.

Market Dynamics

Rise in Geriatric Population

The rise in the geriatric population is one of the significant drivers that drive the market growth in the forecast period. The rise in the population of older people led to increasing the respiratory monitoring devices since the immune system of a person gets weak at this age where the requirement of respiratory monitoring devices is essential to use, which indeed helps the market to grow during the forecast period.

For instance, according to the article published in NCBI, being a smoker, an alcoholic, polypharmacy, and the presence of additional co-morbidities were factors that affected the treatment results of older adults infected with respiratory diseases which indeed needed respiratory monitoring devices that helps the market to grow in future.

Increasing Healthcare Expenditure

The respiratory care devices market is driven by rising healthcare expenditures in developed and developing nations. This is due to those nations' governments are spending in enhancing the quality of healthcare facilities. Furthermore, factors such as rising healthcare spending per capita in emerging nations, mainly due to increased government initiatives, will likely boost treatment affordability and accessibility, aiding market expansion.

For instance, according to the Forum of International Respiratory Societies, Asthma and COPD cause around 489,000 fatalities per year, or more than 1300 deaths per day, and impact more than 200 million people worldwide, with 65 million having moderate or severe airway disease. As a result, the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease and asthma is propelling the market forward.

Lack of Awareness of Respiratory Monitoring Devices

One of the restraints to market growth is a lack of awareness of respiratory monitoring devices. The lack of information and utilization of the devices will lead to a reduction in market growth.

Many conditions affect the market, including individuals unaware of these devices and failing to recognize the early signs and symptoms of respiratory disorders or the need to monitor their respiratory health. This causes delays in seeking medical attention, leading to delayed diagnosis and treatment.

COVID-19 Impact Analysis

With the growth of COVID-19 cases worldwide, the need for respiratory monitoring devices, including pulse oximeters, ventilators, and spirometers, has skyrocketed. These devices are critical for monitoring oxygen saturation levels, lung function, and respiratory assistance to patients suffering from acute respiratory distress. Supply chain issues have also been a factor, with growing demand for respiratory monitoring equipment putting strain on the worldwide supply chain.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global respiratory monitoring devices market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global respiratory monitoring devices market growth over the forecast period.

Segment Analysis

The Global Respiratory Monitoring Devices Market is segmented based on product, end user and region.

The Peak Flow Meters Product Segment Accounted for Approximately 24.9% of the Respiratory Monitoring Devices Market Share

The peak flow meter devices are used to measure the rate of breathing. Peak flow meters that are lightweight, simple to handle and transport, and remotely accessible are in high demand. For instance, On April 18 2023, Tenovi has introduced a cellular FDA-cleared remote peak flow meter (PFM) for advanced remote physiological monitoring of asthmatic patients.

When combined with Tenovi's cellular gateway, the device allows patients with asthma to transmit peak expiratory flow rate (PEF) and 1-second forced expiratory volume (fev1) readings instantly to clinicians. Asthma is a chronic respiratory condition that affects millions of people worldwide, and effective monitoring of asthmatic symptoms is essential for proper management.

Geographical Analysis

North America Accounted for Approximately 39.5% of the Market Share Owing to the Strong Presence of Major Players.

North America is estimated to hold about 39.5% of the total market share throughout the forecast period. The dominating market, such as the United States, is distinguished by increased healthcare expenditures, robust healthcare infrastructure, and enhanced access to healthcare services.

The average per capita healthcare spending in the United States was $40,624 in 2022. Furthermore, rising public awareness of the many sophisticated respiratory monitoring equipment has aided North American respiratory monitoring devices' growth.

Competitive Landscape

The major global players in respiratory monitoring devices include: GE Healthcare, Smith & Nephew, Vyaire (CareFusion Corporation), Masimo Corporation, Medtronic, MGC Diagnostics Corporation, COSMEDN, Nihon Kohden Corporation, Philips Healthcare, and Novelda AS, among others.

Why Purchase the Report?

To visualize the Global Respiratory Monitoring Devices Market segmentation based on product, end user and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of respiratory monitoring devices market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The Global Respiratory Monitoring Devices Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Respiratory Diseases
  - 4.1.1.2. Rise in Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Longer Duration of Approval Process
- 4.1.3. Opportunity
  - 4.1.3.1. Investment by key players in emerging markets
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Spirometer *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Peak Flow Meters
7.4. Sleep Test Devices
7.5. Gas Analyzers
7.6. Pulse Oximeters
7.7. Capnography
7.8. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers
8.4. Homecare
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. The U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. The U.K.
  - 9.3.5.3. France
  - 9.3.5.4. Spain
  - 9.3.5.5. Italy
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan

Australia

9.5.5.4. Rest of Asia-Pacific

9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. GE Healthcare *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Smith & Nephew
11.3. Vyaire (Carefusion Corporation)
11.4. Masimo Corporation
11.5. Medtronic plc
11.6. MGC Diagnostics Corporation
11.7. COSMED
11.8. Nihon Kohden Corporation
11.9. Philips Healthcare
11.10. Novelda AS

LIST NOT EXHAUSTIVE